CDAZX
Price
$7.48
Change
-$0.00 (-0.00%)
Updated
Sep 18 closing price
QLENX
Price
$15.57
Change
-$0.00 (-0.00%)
Updated
Sep 18 closing price
Ad is loading...

CDAZX vs QLENX

Header iconCDAZX vs QLENX Comparison
Open Charts CDAZX vs QLENXBanner chart's image
Multi-Manager Directional Alt Strat Inst
Price$7.48
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
AQR Long-Short Equity N
Price$15.57
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
CDAZX vs QLENX Comparison Chart
Loading...
VS
CDAZX vs. QLENX commentary
Sep 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDAZX is a Buy and QLENX is a Hold.

FUNDAMENTALS
Fundamentals
QLENX has more cash in the bank: 1.93B vs. CDAZX (276M). QLENX pays higher dividends than CDAZX: QLENX (18.52) vs CDAZX (1.24). CDAZX was incepted earlier than QLENX: CDAZX (8 years) vs QLENX (11 years). CDAZX is a more actively managed with annual turnover of: 399.00 vs. QLENX (0.00). CDAZX has a lower initial minimum investment than QLENX: CDAZX (100) vs QLENX (2500). QLENX annual gain was more profitable for investors over the last year : 24.28 vs. CDAZX (14.69). QLENX return over 5 years is better than : 94.94 vs. CDAZX (16.83).
CDAZXQLENXCDAZX / QLENX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years11 years-
Gain YTD10.48720.76251%
Front LoadN/AN/A-
Min. Initial Investment10025004%
Min. Initial Investment IRAN/AN/A-
Net Assets276M1.93B14%
Annual Yield % from dividends1.2418.527%
Returns for 1 year14.6924.2861%
Returns for 3 years7.9589.239%
Returns for 5 years16.8394.9418%
Returns for 10 yearsN/A121.35-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OM0.650.12
+22.39%
Outset Medical
FA19.660.16
+0.82%
First Advantage Corp
KRT25.94-0.01
-0.04%
Karat Packaging
UNM56.24-0.16
-0.28%
Unum Group
GLMD6.83-8.27
-54.77%
Galmed Pharmaceuticals Ltd